The summer of 2018, American consumers saw a number of larger drug recalls, including the contaminated valsartan medication found in July and the hydrochlorothiazide tablets that were mislabeled in August. These two medications in particular impacted thousands of consumers with high blood pressure, and it’s worth noting that they also raised many general questions about… Continue reading Responding to a Consumer Drug Recall